Tag: biopharmaceutical excipients industry

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Biopharmaceutical Excipients Market Size Outlook: How Quickly Will Revenue Expand Through 2030?

The biopharmaceutical excipients market size has experienced robust growth in recent years. This market is projected to expand from $3.27 billion in 2025 to $3.57 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.2%. Historically, this growth can be attributed to several factors including increasing biologic drug approvals, the early adoption of protein stabilizers, a rise in injectable formulations, the expansion of vaccine development, and advancements in formulation science.

The biopharmaceutical excipients market size is anticipated to experience robust expansion over the next few years. This market is projected to reach $5.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period can be attributed to factors such as the increasing complexity of biologic formulations, a rising demand for products with extended shelf lives, the expansion of cell and gene therapies, a heightened regulatory focus on excipient safety, and increased investments in advanced drug delivery systems. Major trends expected in this period include a growing demand for high-purity biologic excipients, an increasing use of multifunctional formulation ingredients, the broadening application of excipients for cell and gene therapies, a rising emphasis on stability-enhancing compounds, and more tailored customization of excipient solutions.

Get A Free Sample Report With In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30214&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Biopharmaceutical Excipients Market Demand Drivers: What’s Powering Industry Growth?

The expanding need for vaccine creation is projected to fuel the advancement of the biopharmaceutical excipients market moving ahead. Vaccine creation involves the method of designing and producing immunizations to combat infectious illnesses and enhance public well-being, necessitating premium excipients for the stability, effectiveness, and security of these vaccine products. This rising demand for vaccine development originates from a worldwide emphasis on avoiding infectious ailments, bolstering public health readiness, and expediting research to provide quicker and more potent immunization options. Biopharmaceutical excipients are crucial in vaccine formulations, as they stabilize antigens, boost solubility, and preserve integrity throughout storage and distribution. An illustration of this trend is seen in 2025, when the Centers for Disease Control and Prevention, a US-based national public health agency, reported an increase in adolescent vaccination coverage for critical vaccines like tetanus, diphtheria, and acellular pertussis from 89.9% in 2022 to 91.3% in 2024. During the identical timeframe, meningococcal conjugate vaccine coverage climbed from 88.6% to 90.1%, and human papillomavirus vaccine coverage (=2 doses) saw a substantial rise from 76.0% to 92.6%. Consequently, the expanding need for vaccine development is propelling the expansion of the biopharmaceutical excipients market.

Biopharmaceutical Excipients Market Segment Landscape: Which Areas Lead Development?

The biopharmaceutical excipients market covered in this report is segmented –

1) By Product Types: Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents

2) By Type Of Biologics: Antibodies, Vaccines, Cell Therapies, Other Biologics

3) By Functionality: Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives

4) By Application: Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy

5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes

Subsegments:

1) By Binders: Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders

2) By Coatings: Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings

3) By Diluents: Lactose, Microcrystalline Cellulose, Starch, Mannitol

4) By Disintegrants: Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate

5) By Lubricants And Glidants: Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide

6) By Polyols: Sorbitol, Mannitol, Glycerol, Xylitol

7) By Preservatives: Parabens, Benzoates, Sorbates, Phenols

8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate

9) By Suspending And Viscosity Agents: Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers

Biopharmaceutical Excipients Market Innovation Trends: What Developments Are Reshaping The Industry?

Leading companies within the biopharmaceutical excipients market are emphasizing technological advancements, including ultra-high purity surfactants, aimed at improving protein stability, preventing degradation, and ensuring regulatory compliance for injectable formulations. These ultra-high purity surfactants consist of precisely refined surface-active agents that possess minimal impurities and a consistent composition, specifically formulated to guarantee stability, safety, and optimal performance in delicate pharmaceutical and biopharmaceutical preparations. An example of this trend occurred in September 2025, when Evonik Industries AG, a Germany-based chemicals company, unveiled MaxiPure Polysorbate 80, intended for injectable and biopharmaceutical applications. This particular excipient has been developed to feature an oleic acid content surpassing ninety-eight percent, remarkable clarity, and complete adherence to European Pharmacopoeia, United States Pharmacopoeia, Japanese Pharmacopoeia, and Chinese Pharmacopoeia standards. It effectively tackles significant issues regarding protein stability, inhibits oxidative degradation, facilitates reliable solubilization of hydrophobic active pharmaceutical ingredients, and boosts overall formulation reliability. Through the incorporation of this excipient, Evonik supports pharmaceutical and biopharmaceutical companies in the efficient development of complex biologics and injectable therapies, simultaneously ensuring both safety and compliance.

Biopharmaceutical Excipients Market Industry Leaders And Competitive Landscape

Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Frères, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Söhne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.

View The Full Biopharmaceutical Excipients Market Report:

https://www.thebusinessresearchcompany.com/report/global-biopharmaceutical-excipients-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Biopharmaceutical Excipients Market Geographic Spread And Regional Opportunities

North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Biopharmaceutical Excipients Market Growth From $3.57 Billion In 2026 To $5.03 Billion By 2030 At A CAGR Of 9%

The biopharmaceutical excipients sector has experienced robust expansion over the past few years. Its market valuation is projected to rise from $3.27 billion in 2025 to $3.57 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.2%. This historic growth has been driven by factors including a higher number of biologic drug approvals, the early implementation of protein stabilizers, the increasing use of injectable formulations, the growth of vaccine development efforts, and improvements in formulation science.

The biopharmaceutical excipients market is projected to experience robust expansion over the coming years, reaching a value of $5.04 billion by 2030, with a compound annual growth rate (CAGR) of 9.0%. This anticipated growth during the forecast period is driven by factors such as the heightened complexity of biologic formulations, a growing need for products with extended shelf lives, the expansion of cell and gene therapies, stricter regulatory scrutiny regarding excipient safety, and increased investments in sophisticated drug delivery systems. Key trends shaping the market include a rising preference for high-purity biologic excipients, broader adoption of multifunctional ingredients in formulations, the development of excipients specifically designed for cell and gene therapies, a greater emphasis on compounds that enhance stability, and more tailored excipient solutions to meet specific requirements.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30214&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Biopharmaceutical Excipients Market Expansion Drivers: What Is Shaping Future Growth?

The rising need for vaccine development is anticipated to fuel expansion in the biopharmaceutical excipients market moving forward. Vaccine development involves the creation and formulation of immunizations designed to prevent infectious diseases and enhance public health, depending on premium excipients to maintain the stability, effectiveness, and safety of vaccine products. This increasing demand is driven by a global emphasis on combating infectious diseases, bolstering public health readiness, and accelerating research to provide quicker and more efficient immunization options. Biopharmaceutical excipients are essential in vaccine formulations, as they stabilize antigens, improve solubility, and preserve product integrity during storage and transport. For example, in 2025, the Centers for Disease Control and Prevention, a US national public health agency, reported that adolescent vaccination coverage for key vaccines like tetanus, diphtheria, and acellular pertussis climbed from 89.9% in 2022 to 91.3% in 2024, meningococcal conjugate vaccine coverage increased from 88.6% to 90.1%, and human papillomavirus vaccine coverage (with two or more doses) rose markedly from 76.0% to 92.6% during the same timeframe. Consequently, the growing demand for vaccine development is propelling the biopharmaceutical excipients market forward.

Biopharmaceutical Excipients Market Segment Outlook: Which Categories Are Expanding The Fastest?

The biopharmaceutical excipients market covered in this report is segmented –

1) By Product Types: Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents

2) By Type Of Biologics: Antibodies, Vaccines, Cell Therapies, Other Biologics

3) By Functionality: Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives

4) By Application: Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy

5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes

Subsegments:

1) By Binders: Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders

2) By Coatings: Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings

3) By Diluents: Lactose, Microcrystalline Cellulose, Starch, Mannitol

4) By Disintegrants: Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate

5) By Lubricants And Glidants: Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide

6) By Polyols: Sorbitol, Mannitol, Glycerol, Xylitol

7) By Preservatives: Parabens, Benzoates, Sorbates, Phenols

8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate

9) By Suspending And Viscosity Agents: Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers

Biopharmaceutical Excipients Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Major players in the biopharmaceutical excipients industry are prioritizing technological advancements, particularly the development of ultra-high purity surfactants, to enhance protein stability, minimize degradation, and ensure adherence to regulatory standards in injectable formulations. These surfactants are meticulously processed active agents characterized by extremely low impurity levels and uniform composition, guaranteeing stability, safety, and optimal performance in delicate pharmaceutical and biopharmaceutical products. For example, in September 2025, Evonik Industries AG, a chemical company based in Germany, unveiled MaxiPure Polysorbate 80 tailored for injectable and biopharmaceutical uses. This excipient boasts an oleic acid content exceeding ninety-eight percent, outstanding clarity, and complete alignment with European, United States, Japanese, and Chinese pharmacopoeial requirements. It effectively tackles key obstacles related to protein stability, curbs oxidative degradation, provides consistent solubilization for hydrophobic active ingredients, and bolsters formulation dependability. By incorporating this excipient, Evonik assists pharmaceutical and biopharmaceutical firms in effectively creating intricate biologics and injectable treatments while maintaining compliance and efficacy.

Biopharmaceutical Excipients Market Key Companies And Competitive Benchmarking

Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Frères, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Söhne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.

Access The Complete Biopharmaceutical Excipients Market Report:

https://www.thebusinessresearchcompany.com/report/global-biopharmaceutical-excipients-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Biopharmaceutical Excipients Market Geographic Analysis: Where Is Demand Growing The Fastest?

North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Biopharmaceutical Excipients Market Growth From $3.57 Billion In 2026 To $5.03 Billion By 2030 At A CAGR Of 9%

The biopharmaceutical excipients sector has experienced robust expansion over the past few years. Its market valuation is projected to rise from $3.27 billion in 2025 to $3.57 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.2%. This historic growth has been driven by factors including a higher number of biologic drug approvals, the early implementation of protein stabilizers, the increasing use of injectable formulations, the growth of vaccine development efforts, and improvements in formulation science.

The biopharmaceutical excipients market is projected to experience robust expansion over the coming years, reaching a value of $5.04 billion by 2030, with a compound annual growth rate (CAGR) of 9.0%. This anticipated growth during the forecast period is driven by factors such as the heightened complexity of biologic formulations, a growing need for products with extended shelf lives, the expansion of cell and gene therapies, stricter regulatory scrutiny regarding excipient safety, and increased investments in sophisticated drug delivery systems. Key trends shaping the market include a rising preference for high-purity biologic excipients, broader adoption of multifunctional ingredients in formulations, the development of excipients specifically designed for cell and gene therapies, a greater emphasis on compounds that enhance stability, and more tailored excipient solutions to meet specific requirements.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30214&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Biopharmaceutical Excipients Market Expansion Drivers: What Is Shaping Future Growth?

The rising need for vaccine development is anticipated to fuel expansion in the biopharmaceutical excipients market moving forward. Vaccine development involves the creation and formulation of immunizations designed to prevent infectious diseases and enhance public health, depending on premium excipients to maintain the stability, effectiveness, and safety of vaccine products. This increasing demand is driven by a global emphasis on combating infectious diseases, bolstering public health readiness, and accelerating research to provide quicker and more efficient immunization options. Biopharmaceutical excipients are essential in vaccine formulations, as they stabilize antigens, improve solubility, and preserve product integrity during storage and transport. For example, in 2025, the Centers for Disease Control and Prevention, a US national public health agency, reported that adolescent vaccination coverage for key vaccines like tetanus, diphtheria, and acellular pertussis climbed from 89.9% in 2022 to 91.3% in 2024, meningococcal conjugate vaccine coverage increased from 88.6% to 90.1%, and human papillomavirus vaccine coverage (with two or more doses) rose markedly from 76.0% to 92.6% during the same timeframe. Consequently, the growing demand for vaccine development is propelling the biopharmaceutical excipients market forward.

Biopharmaceutical Excipients Market Segment Outlook: Which Categories Are Expanding The Fastest?

The biopharmaceutical excipients market covered in this report is segmented –

1) By Product Types: Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents

2) By Type Of Biologics: Antibodies, Vaccines, Cell Therapies, Other Biologics

3) By Functionality: Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives

4) By Application: Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy

5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes

Subsegments:

1) By Binders: Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders

2) By Coatings: Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings

3) By Diluents: Lactose, Microcrystalline Cellulose, Starch, Mannitol

4) By Disintegrants: Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate

5) By Lubricants And Glidants: Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide

6) By Polyols: Sorbitol, Mannitol, Glycerol, Xylitol

7) By Preservatives: Parabens, Benzoates, Sorbates, Phenols

8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate

9) By Suspending And Viscosity Agents: Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers

Biopharmaceutical Excipients Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Major players in the biopharmaceutical excipients industry are prioritizing technological advancements, particularly the development of ultra-high purity surfactants, to enhance protein stability, minimize degradation, and ensure adherence to regulatory standards in injectable formulations. These surfactants are meticulously processed active agents characterized by extremely low impurity levels and uniform composition, guaranteeing stability, safety, and optimal performance in delicate pharmaceutical and biopharmaceutical products. For example, in September 2025, Evonik Industries AG, a chemical company based in Germany, unveiled MaxiPure Polysorbate 80 tailored for injectable and biopharmaceutical uses. This excipient boasts an oleic acid content exceeding ninety-eight percent, outstanding clarity, and complete alignment with European, United States, Japanese, and Chinese pharmacopoeial requirements. It effectively tackles key obstacles related to protein stability, curbs oxidative degradation, provides consistent solubilization for hydrophobic active ingredients, and bolsters formulation dependability. By incorporating this excipient, Evonik assists pharmaceutical and biopharmaceutical firms in effectively creating intricate biologics and injectable treatments while maintaining compliance and efficacy.

Biopharmaceutical Excipients Market Key Companies And Competitive Benchmarking

Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Frères, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Söhne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.

Access The Complete Biopharmaceutical Excipients Market Report:

https://www.thebusinessresearchcompany.com/report/global-biopharmaceutical-excipients-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Biopharmaceutical Excipients Market Geographic Analysis: Where Is Demand Growing The Fastest?

North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Biopharmaceutical Excipients Market From 2026 To 2030?

The biopharmaceutical excipients market size has seen significant growth over recent years. It is projected to expand from $3.27 billion in 2025 to $3.57 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.2%. The historical period’s expansion was driven by increasing biologic drug approvals, early adoption of protein stabilizers, growth in injectable formulations, the expansion of vaccine development, and advancements in formulation science.

The biopharmaceutical excipients market is anticipated to experience robust expansion over the coming years. Its valuation is projected to reach $5.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This projected growth stems from several factors, including the increasing intricacy of biologic formulations, a surging need for products with extended shelf lives, the broadening scope of cell and gene therapies, heightened regulatory scrutiny on excipient safety, and greater investments in sophisticated drug delivery systems. Key developments expected during this timeframe encompass a rising requirement for high-purity biologic excipients, the broader adoption of multifunctional formulation components, an increase in excipients tailored for cell and gene therapies, an intensifying emphasis on compounds that enhance stability, and greater personalization of excipient offerings.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30214&type=smp

What Primary Factors Are Fueling The Expansion Of The Biopharmaceutical Excipients Market?

The anticipated expansion of the biopharmaceutical excipients market is linked to the increasing need for vaccine development moving forward. Vaccine development involves creating and formulating immunizations to prevent infectious diseases and enhance public health, relying on premium excipients to guarantee the stability, effectiveness, and safety of these products. This rising demand for vaccine development arises from a worldwide emphasis on preventing infectious diseases, bolstering public health readiness, and expediting research to provide more rapid and potent immunization options. Within vaccine formulations, biopharmaceutical excipients serve a crucial function by stabilizing antigens, improving solubility, and preserving integrity throughout storage and distribution. For example, in 2025, according to the Centers for Disease Control and Prevention, a US-based national public health agency, adolescent vaccination coverage for key vaccines such as tetanus, diphtheria, and acellular pertussis increased from 89.9% in 2022 to 91.3% in 2024, meningococcal conjugate vaccine coverage rose from 88.6% to 90.1%; and human papillomavirus vaccine coverage (=2 doses) grew significantly from 76.0% to 92.6% over the same period. Consequently, the increasing need for vaccine development is fueling the expansion of the biopharmaceutical excipients market.

What Segment Categories Are Evaluated In The Biopharmaceutical Excipients Market Study?

The biopharmaceutical excipients market covered in this report is segmented –

1) By Product Types: Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents

2) By Type Of Biologics: Antibodies, Vaccines, Cell Therapies, Other Biologics

3) By Functionality: Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives

4) By Application: Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy

5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes

Subsegments:

1) By Binders: Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders

2) By Coatings: Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings

3) By Diluents: Lactose, Microcrystalline Cellulose, Starch, Mannitol

4) By Disintegrants: Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate

5) By Lubricants And Glidants: Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide

6) By Polyols: Sorbitol, Mannitol, Glycerol, Xylitol

7) By Preservatives: Parabens, Benzoates, Sorbates, Phenols

8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate

9) By Suspending And Viscosity Agents: Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers

What Trends Are Affecting The Biopharmaceutical Excipients Market Dynamics?

Key players in the biopharmaceutical excipients market are prioritizing technological advancements, such as ultra-high purity surfactants, to improve protein stability, prevent degradation, and support regulatory adherence in injectable formulations. Ultra-high purity surfactants are specifically refined surface-active agents with minimal impurities and a consistent composition, engineered to ensure stability, safety, and performance in sensitive pharmaceutical and biopharmaceutical preparations. For instance, in September 2025, Evonik Industries AG, a Germany-based chemicals company, unveiled MaxiPure Polysorbate 80 for injectable and biopharmaceutical applications. This excipient is designed with an oleic acid content exceeding ninety-eight percent, superior clarity, and full compliance with European Pharmacopoeia, United States Pharmacopoeia, Japanese Pharmacopoeia, and Chinese Pharmacopoeia standards. It addresses significant challenges in protein stability, prevents oxidative degradation, facilitates consistent solubilization of hydrophobic active pharmaceutical ingredients, and enhances formulation reliability. Through the integration of this excipient, Evonik empowers pharmaceutical and biopharmaceutical companies to efficiently develop complex biologics and injectable therapies while guaranteeing safety and compliance.

Who Are The Leading Firms Participating In The Biopharmaceutical Excipients Market?

Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Frères, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Söhne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.

Access The Complete Biopharmaceutical Excipients Market Report:

https://www.thebusinessresearchcompany.com/report/global-biopharmaceutical-excipients-market-report

Which Region Contributes The Most To The Biopharmaceutical Excipients Market?

North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Biopharmaceutical Excipients Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=30214&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical Excipients Market 2026, By The Business Research Company

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Organic Pharmaceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/organic-pharmaceutical-excipients-global-market-report

Nutraceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/nutraceutical-excipients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Biopharmaceutical Excipients Market Progress Between 2026 And 2030?

The biopharmaceutical excipients market has demonstrated robust expansion over recent years. Its valuation is expected to rise from $3.27 billion in 2025 to $3.57 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. This historical growth can be attributed to several factors including a rise in biologic drug approvals, the early implementation of protein stabilizers, an increase in injectable formulations, the broader development of vaccines, and progress in formulation science.

The biopharmaceutical excipients market is poised for robust expansion in the coming years. It is projected to achieve a value of $5.04 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. This anticipated growth can be attributed to several factors, including the increasing intricacy of biologic formulations, a surging demand for products with extended shelf lives, the ongoing expansion of cell and gene therapies, an intensifying regulatory focus on excipient safety, and increased investments in sophisticated drug delivery systems. Key trends anticipated within this period include a heightened demand for high-purity biologic excipients, a growing utilization of multifunctional formulation ingredients, the broadening application of excipients for cell and gene therapies, an increased emphasis on stability-enhancing compounds, and greater customization of excipient solutions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30214&type=smp

Which Major Drivers Are Influencing The Expansion Of The Biopharmaceutical Excipients Market?

The expanding need for vaccine creation is projected to drive the future expansion of the biopharmaceutical excipients market. Vaccine creation involves the method of designing and preparing immunizations aimed at preventing infectious illnesses and enhancing public health, with a dependence on superior excipients to guarantee the stability, effectiveness, and safety of the final vaccine products. This rising requirement for vaccine development originates from a worldwide emphasis on preventing infectious diseases, enhancing readiness in public health, and speeding up research to provide more rapid and potent immunization solutions. Within vaccine formulations, biopharmaceutical excipients perform an essential function by stabilizing antigens, improving solubility, and preserving integrity during storage and distribution. For example, data from 2025, provided by the Centers for Disease Control and Prevention, a US-based national public health agency, indicates that adolescent vaccination rates for important vaccines such as tetanus, diphtheria, and acellular pertussis climbed from 89.9% in 2022 to 91.3% in 2024. Meningococcal conjugate vaccine coverage also saw an increase from 88.6% to 90.1%; and human papillomavirus vaccine coverage (=2 doses) expanded considerably from 76.0% to 92.6% during this identical timeframe. Consequently, the escalating demand for vaccine development is fueling the growth of the biopharmaceutical excipients market.

How Are Different Segments Classified In The Biopharmaceutical Excipients Market Segment Analysis?

The biopharmaceutical excipients market covered in this report is segmented –

1) By Product Types: Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents

2) By Type Of Biologics: Antibodies, Vaccines, Cell Therapies, Other Biologics

3) By Functionality: Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives

4) By Application: Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy

5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes

Subsegments:

1) By Binders: Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders

2) By Coatings: Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings

3) By Diluents: Lactose, Microcrystalline Cellulose, Starch, Mannitol

4) By Disintegrants: Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate

5) By Lubricants And Glidants: Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide

6) By Polyols: Sorbitol, Mannitol, Glycerol, Xylitol

7) By Preservatives: Parabens, Benzoates, Sorbates, Phenols

8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate

9) By Suspending And Viscosity Agents: Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers

Which Trends Are Contributing To Changes In The Biopharmaceutical Excipients Market?

Key players within the biopharmaceutical excipients sector are increasingly emphasizing technological advancements, including ultra-high purity surfactants, to enhance protein stability, mitigate degradation, and ensure adherence to regulatory standards for injectable products. These surfactants represent highly refined surface-active compounds, characterized by extremely low impurity levels and a uniform makeup, specifically developed to guarantee stability, safety, and optimal performance in delicate pharmaceutical and biopharmaceutical preparations. An example of this innovation is the launch of MaxiPure Polysorbate 80 by Evonik Industries AG, a German chemicals company, in September 2025, targeting injectable and biopharmaceutical applications. This particular excipient is formulated with an oleic acid concentration surpassing ninety-eight percent, boasts remarkable clarity, and fully conforms to the rigorous standards set by the European Pharmacopoeia, United States Pharmacopoeia, Japanese Pharmacopoeia, and Chinese Pharmacopoeia. Its capabilities include tackling crucial issues in protein stability, inhibiting oxidative breakdown, facilitating the consistent solubilization of hydrophobic active pharmaceutical ingredients, and bolstering overall formulation reliability. The incorporation of this excipient allows Evonik to support pharmaceutical and biopharmaceutical companies in the efficient development of intricate biologics and injectable therapies, simultaneously guaranteeing both safety and regulatory adherence.

Who Are The Companies Driving Activity In The Biopharmaceutical Excipients Market?

Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Frères, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Söhne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.

Get The Full Biopharmaceutical Excipients Market Report:

https://www.thebusinessresearchcompany.com/report/global-biopharmaceutical-excipients-market-report

Which Region Accounts For The Largest Portion Of The Biopharmaceutical Excipients Market?

North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Biopharmaceutical Excipients Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/global-biopharmaceutical-excipients-market-report

Browse Through More Reports Similar to the Global Biopharmaceutical Excipients Market 2026, By The Business Research Company

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Organic Pharmaceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/organic-pharmaceutical-excipients-global-market-report

Nutraceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/nutraceutical-excipients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Biopharmaceutical Excipients Market Across 2026–2030?

The biopharmaceutical excipients market size has shown robust growth recently. It is anticipated to expand from $3.27 billion in 2025 to $3.57 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. The historical growth of this market is attributable to the rise in biologic drug approvals, the early acceptance of protein stabilizers, an increase in injectable formulations, the broadening of vaccine development, and progress in formulation science.

The biopharmaceutical excipients market is projected to experience substantial expansion in the coming years. This market is forecast to reach $5.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. Key factors contributing to this growth during the forecast period include the escalating complexity of biologic formulations, a surging demand for products with extended shelf lives, the broadening application of cell and gene therapies, an enhanced regulatory emphasis on excipient safety, and increased investments in sophisticated drug delivery systems. Significant trends anticipated in this period encompass a heightened demand for high-purity biologic excipients, the expanding utilization of multifunctional formulation components, the development of excipients specifically for cell and gene therapies, a concentrated effort on stability-improving compounds, and greater customization of excipient solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30214&type=smp

Which Market Drivers Are Supporting The Expansion Of The Biopharmaceutical Excipients Market?

The expanding requirement for vaccine creation is anticipated to drive growth in the biopharmaceutical excipients market. Vaccine development encompasses the creation and formulation of immunizations designed to prevent infectious diseases and enhance public health, relying on superior excipients to guarantee the stability, effectiveness, and safety of vaccine products. This escalating need for vaccine development originates from a worldwide focus on averting infectious diseases, strengthening public health preparedness, and accelerating research to provide quicker and more potent immunization solutions. Biopharmaceutical excipients play a vital role in vaccine formulations by stabilizing antigens, improving solubility, and maintaining integrity throughout storage and distribution. For illustration, in 2025, data from the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that adolescent vaccination coverage for critical vaccines such as tetanus, diphtheria, and acellular pertussis rose from 89.9% in 2022 to 91.3% in 2024. Furthermore, meningococcal conjugate vaccine coverage increased from 88.6% to 90.1%, and human papillomavirus vaccine coverage (=2 doses) saw substantial growth from 76.0% to 92.6% during the same period. Thus, the rising demand for vaccine development is propelling the expansion of the biopharmaceutical excipients market.

What Segmentation Levels Are Considered In The Biopharmaceutical Excipients Market?

The biopharmaceutical excipients market covered in this report is segmented –

1) By Product Types: Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents

2) By Type Of Biologics: Antibodies, Vaccines, Cell Therapies, Other Biologics

3) By Functionality: Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives

4) By Application: Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy

5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes

Subsegments:

1) By Binders: Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders

2) By Coatings: Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings

3) By Diluents: Lactose, Microcrystalline Cellulose, Starch, Mannitol

4) By Disintegrants: Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate

5) By Lubricants And Glidants: Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide

6) By Polyols: Sorbitol, Mannitol, Glycerol, Xylitol

7) By Preservatives: Parabens, Benzoates, Sorbates, Phenols

8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate

9) By Suspending And Viscosity Agents: Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers

What Trends Are Projected To Affect The Biopharmaceutical Excipients Market?

Leading companies in the biopharmaceutical excipients market are prioritizing technological advancements, such as ultra-high purity surfactants, to enhance protein stability, prevent degradation, and support regulatory compliance in injectable formulations. Ultra-high purity surfactants are highly refined surface-active agents characterized by minimal impurities and a consistent composition, specifically designed to ensure stability, safety, and performance in sensitive pharmaceutical and biopharmaceutical formulations. For instance, in September 2025, Evonik Industries AG, a Germany-based chemicals company, unveiled MaxiPure Polysorbate 80, tailored for injectable and biopharmaceutical applications. This excipient is engineered with an oleic acid content exceeding ninety-eight percent, demonstrates exceptional clarity, and fully complies with European Pharmacopoeia, United States Pharmacopoeia, Japanese Pharmacopoeia, and Chinese Pharmacopoeia standards. It addresses crucial issues related to protein stability, prevents oxidative degradation, facilitates consistent solubilization of hydrophobic active pharmaceutical ingredients, and boosts formulation reliability. By integrating this excipient, Evonik enables pharmaceutical and biopharmaceutical companies to efficiently develop complex biologics and injectable therapies while ensuring safety and compliance.

Which Leading Firms Are Contributing To The Growth Of The Biopharmaceutical Excipients Market?

Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Frères, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Söhne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.

Read the full biopharmaceutical excipients market report here:

https://www.thebusinessresearchcompany.com/report/global-biopharmaceutical-excipients-market-report

How Is The Biopharmaceutical Excipients Market Distributed Across Key Geographic Regions?

North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biopharmaceutical Excipients Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30214&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical Excipients Market 2026, By The Business Research Company

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Organic Pharmaceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/organic-pharmaceutical-excipients-global-market-report

Nutraceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/nutraceutical-excipients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the biopharmaceutical excipients market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Biopharmaceutical Excipients Market between 2026 and 2030?

The biopharmaceutical excipients market has experienced robust expansion in recent years. Projections indicate it will increase from $3.27 billion in 2025 to $3.57 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. Historically, this growth can be attributed to factors such as an uptick in biologic drug approvals, the prompt adoption of protein stabilizers, an increase in injectable formulations, the broader scope of vaccine development, and advancements in formulation science.

The biopharmaceutical excipients market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $5.04 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. Factors contributing to this growth during the forecast period include the increasing intricacy of biologic formulations, a surging need for products with extended shelf lives, the broadening scope of cell and gene therapies, heightened regulatory scrutiny on excipient safety, and greater investments in sophisticated drug delivery systems. Key trends anticipated during the same period involve a heightened demand for high-purity biologic excipients, the increasing adoption of multifunctional ingredients in formulations, an expansion of excipient applications for cell and gene therapies, an elevated emphasis on compounds that improve stability, and greater customization of excipient solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30214&type=smp

Which Drivers Are Expected To Impact The Biopharmaceutical Excipients Market During The Forecast Period?

The increasing need for creating vaccines is anticipated to drive the expansion of the biopharmaceutical excipients market in the future. Developing vaccines involves the creation and formulation of immunizations aimed at preventing infectious illnesses and enhancing public well-being, necessitating premium excipients to guarantee the robustness, effectiveness, and security of vaccine offerings. This rising demand for vaccine creation arises from a worldwide emphasis on combating infectious illnesses, boosting readiness in public health, and speeding up research to provide quicker and more potent immunization options. Biopharmaceutical excipients are crucial in vaccine formulations, as they stabilize antigens, improve solubility, and preserve structural integrity throughout their storage and distribution. For example, by 2025, data from the Centers for Disease Control and Prevention, a national public health agency based in the US, indicated that adolescent vaccination rates for essential vaccines like tetanus, diphtheria, and acellular pertussis climbed from 89.9% in 2022 to 91.3% in 2024. During the identical timeframe, coverage for the meningococcal conjugate vaccine increased from 88.6% to 90.1%, while human papillomavirus vaccine coverage (≥2 doses) saw a substantial rise from 76.0% to 92.6%. Consequently, the escalating requirement for vaccine creation is propelling the expansion of the biopharmaceutical excipients market.

Which Segments Are Driving Activity In The Biopharmaceutical Excipients Market?

The biopharmaceutical excipients market covered in this report is segmented –

1) By Product Types: Binders, Coatings, Diluents, Disintegrants, Lubricants And Glidants, Polyols, Preservatives, Solubilizers And Surfactants Or Emulsifiers, Suspending And Viscosity Agents

2) By Type Of Biologics: Antibodies, Vaccines, Cell Therapies, Other Biologics

3) By Functionality: Fillers And Diluents, Binders, Suspending And Viscosity Agents, Flavouring Agents And Sweeteners, Coating Agents, Colourants, Disintegrants, Lubricants And Glidants, Preservatives

4) By Application: Injectable Formulations, Oral Formulations, Topical Formulations, Transdermal Formulations, Cell and Gene Therapy

5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies, Contract Manufacturers, Research Institutes

Subsegments:

1) By Binders: Starch Binders, Cellulose Binders, Synthetic Binders, Natural Polymer Binders

2) By Coatings: Film Coatings, Sugar Coatings, Enteric Coatings, Polymer Coatings

3) By Diluents: Lactose, Microcrystalline Cellulose, Starch, Mannitol

4) By Disintegrants: Crosslinked Cellulose, Starch Derivatives, Crospovidone, Sodium Starch Glycolate

5) By Lubricants And Glidants: Magnesium Stearate, Stearic Acid, Talc, Silicon Dioxide

6) By Polyols: Sorbitol, Mannitol, Glycerol, Xylitol

7) By Preservatives: Parabens, Benzoates, Sorbates, Phenols

8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates, Polyethylene Glycol, Lecithin, Sodium Lauryl Sulfate

9) By Suspending And Viscosity Agents: Cellulose Derivatives, Xanthan Gum, Guar Gum, Carbomers

Which Innovation Trends Are Advancing Developments Within The Biopharmaceutical Excipients Market?

Leading companies in the biopharmaceutical excipients market are concentrating on technological advancements, such as ultra-high purity surfactants, to enhance protein stability, prevent degradation, and support regulatory adherence in injectable formulations. Ultra-high purity surfactants are specifically refined surface-active agents featuring minimal impurities and a consistent composition, engineered to ensure stability, safety, and performance within sensitive pharmaceutical and biopharmaceutical formulations. For instance, in September 2025, Evonik Industries AG, a Germany-based chemicals company, introduced MaxiPure Polysorbate 80 for injectable and biopharmaceutical applications. This excipient is formulated with an oleic acid content exceeding ninety-eight percent, remarkable clarity, and complete conformity with European Pharmacopoeia, United States Pharmacopoeia, Japanese Pharmacopoeia, and Chinese Pharmacopoeia standards. It addresses significant challenges in protein stability, prevents oxidative degradation, allows for consistent solubilization of hydrophobic active pharmaceutical ingredients, and strengthens the reliability of formulations. Through the integration of this excipient, Evonik empowers pharmaceutical and biopharmaceutical companies to efficiently develop complex biologics and injectable therapies while ensuring both safety and compliance.

Which Key Players Are Driving Competition In The Biopharmaceutical Excipients Market?

Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Frères, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Söhne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/global-biopharmaceutical-excipients-market-report

Which Region Is Projected To Lead The Biopharmaceutical Excipients Market During The Forecast Period?

North America was the largest region in the biopharmaceutical excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Biopharmaceutical Excipients Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30214&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical Excipients Market 2026, By The Business Research Company

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Organic Pharmaceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/organic-pharmaceutical-excipients-global-market-report

Nutraceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/nutraceutical-excipients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model